BioCentury
ARTICLE | Clinical News

Synthetic AIDS vaccine: Started Phase II trial

May 3, 1993 7:00 AM UTC

United Biomedical Inc. Product: Synthetic AIDS vaccine based on a peptide from the V3 loop Indication: Prevent HIV infection in high-risk population Status: Started Phase II trial ...